Not all clients with CLL require therapy. Despite all latest advancements, the iwCLL nevertheless suggests watchful observation for sufferers with asymptomatic sickness.86 This advice is predicated on no less than two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR). れたかを表しており，円が小さいほどその地点... https://johnc197clt5.laowaiblog.com/profile